Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Gay

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
Current Opinion in Rheumatology|April 5, 2008
Is there a future for small molecule drugs in the treatment of rheumatic diseases?Joanna Stanczyk, Caroline Ospelt, Steffen Gay
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Toll-like receptors and rheumatoid arthritisFabia Brentano, Diego Kyburz, Steffen Gay
Arthritis and Rheumatism|October 4, 2005
The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal modelsElena Neumann, Steffen Gay, Ulf Müller-Ladner
Epigenomics|March 22, 2017
Interplay between genetic and epigenetic mechanisms in rheumatoid arthritisMojca Frank-Bertoncelj, Kerstin Klein, Steffen Gay
Arthritis and Rheumatism|December 30, 2006
Spondylarthritides and related entities: entheses and hypothesesLars C Huber, Falk Moritz, Steffen Gay
Current Rheumatology Reports|May 16, 2002
Role of nuclear factor kappaB in synovial inflammationUlf Müller-Ladner, Renate E Gay, Steffen Gay
Clinical Immunology (Orlando, Fla.)|September 11, 2009
The role of resistin as a regulator of inflammation: Implications for various human pathologiesMária Filková, Martin Haluzík, Steffen Gay, et al.
Current Opinion in Rheumatology|April 23, 2003
Apoptosis in rheumatoid arthritisAnja Baier, Ingmar Meineckel, Steffen Gay, et al.
Clinical Reviews in Allergy & Immunology|August 27, 2009
Epigenetics in rheumatoid arthritisMichelle Trenkmann, Matthias Brock, Caroline Ospelt, et al.
Current Pharmaceutical Design|February 22, 2005
The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritisIngmar Meinecke, Edita Rutkauskaite, Steffen Gay, et al.
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
Current Opinion in Rheumatology|April 5, 2008
Is there a future for small molecule drugs in the treatment of rheumatic diseases?Joanna Stanczyk, Caroline Ospelt, Steffen Gay
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Toll-like receptors and rheumatoid arthritisFabia Brentano, Diego Kyburz, Steffen Gay
Arthritis and Rheumatism|October 4, 2005
The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: new insights from animal modelsElena Neumann, Steffen Gay, Ulf Müller-Ladner
Epigenomics|March 22, 2017
Interplay between genetic and epigenetic mechanisms in rheumatoid arthritisMojca Frank-Bertoncelj, Kerstin Klein, Steffen Gay
Arthritis and Rheumatism|December 30, 2006
Spondylarthritides and related entities: entheses and hypothesesLars C Huber, Falk Moritz, Steffen Gay
Current Rheumatology Reports|May 16, 2002
Role of nuclear factor kappaB in synovial inflammationUlf Müller-Ladner, Renate E Gay, Steffen Gay
Clinical Immunology (Orlando, Fla.)|September 11, 2009
The role of resistin as a regulator of inflammation: Implications for various human pathologiesMária Filková, Martin Haluzík, Steffen Gay, et al.
Current Opinion in Rheumatology|April 23, 2003
Apoptosis in rheumatoid arthritisAnja Baier, Ingmar Meineckel, Steffen Gay, et al.
Clinical Reviews in Allergy & Immunology|August 27, 2009
Epigenetics in rheumatoid arthritisMichelle Trenkmann, Matthias Brock, Caroline Ospelt, et al.
Current Pharmaceutical Design|February 22, 2005
The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritisIngmar Meinecke, Edita Rutkauskaite, Steffen Gay, et al.
Pageof 28